— Know what they know.
Not Investment Advice

AKAN NASDAQ

Akanda Corp.
1W: -22.1% 1M: -56.0% 3M: -48.8% YTD: +152.0% 1Y: +62.7% 3Y: -96.2%
$6.20
-0.11 (-1.74%)
 
Weekly Expected Move ±8.8%
$6 $7 $8 $8 $9
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · Alpha Radar Strong Sell · Power 35 · $200669 mcap · 32174 float · 3787.46% daily turnover · Short 35% of daily vol
Smart Money Score
No convergence signal
Key Statistics
Market Cap$0.2M
52W Range2.2973-209.23424
Volume59,575
Avg Volume1,218,577
Beta1.73
Dividend
Analyst Ratings
No analyst coverage
Company Info
CEOKatharyn Field
Employees8
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
IPO Date2022-03-15
1a, 1b Learoyd Road
New Romney, KE TN28 8XU
GB
44 20 3488 9514
About Akanda Corp.

Akanda Corp., operating through its various subsidiary entities, focuses on the cultivation, production, and distribution of cannabis products. The company's operations span the United Kingdom, Lesotho, and other global regions, with a specific aim to provide cannabis-derived items for medical and wellness purposes. Formed in 2021, Akanda Corp. is based out of its main office in New Romney, United Kingdom.

Recent Insider Trades

NameTypeSharesPriceDate
HRT FINANCIAL LP S-Sale 7,868 $1.29 2026-01-16
HRT FINANCIAL LP P-Purchase 29,036 $1.40 2026-01-15
HRT FINANCIAL LP 0 2026-01-15

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms